roxithromycine mylan 150 mg, comprimé pelliculé
mylan sas - roxithromycine 150 mg - comprimé - 150 mg - pour un comprimé > roxithromycine 150 mg - antibactériens à usage systémique - classe pharmacothérapeutique : antibactériens à usage systémique - code atc : j01fa06 (j : anti-infectieux).il est utilisé pour le traitement de certaines infections bactériennes à germes sensibles (pouvant être détruits par cet antibiotique).
roxithromycine eg 150 mg film-coat. tabl.
eg sa-nv - roxithromycin 150 mg - film-coated tablet - 150 mg - roxithromycin 150 mg - roxithromycin
roxithromycine ranbaxy 150 mg, comprimé pelliculé
ranbaxy pharmacie generiques - roxithromycine 150 mg - comprimé - 150 mg - pour un comprimé > roxithromycine 150 mg - antibacteriens a usage systemique - ce médicament est indiqué dans le traitement de certaines infections bactériennes à germes sensibles.
roxithromycin accedo 150mg filmtabletten
accedo arzneimittel gmbh (8073702) - roxithromycin - filmtablette - roxithromycin (23283) 150 milligramm
roxithromycin/alvia 300mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο
alvia a.e (0000001228) 18 ΧΛΜ.Λ.ΑΘΗΝΩΝ-ΜΑΡΑΘΩΝΟΣ,, ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ, 153 44 - roxithromycin - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 300mg/tab - 0080214831 roxithromycin 300.000000 mg - roxithromycin
roxithromycin/nexus 300mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο
nexus medicals a.e. (0000007314) Λεωφ. Μαραθώνος 22Γ,, 19009, Πικέρμι Αττικής, 190 09 - roxithromycin - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 300mg/tab - 0080214831 roxithromycin 300.000000 mg - roxithromycin
roxithromycin stada 300 mg filmtabletten
stadapharm, gesellschaft mit beschränkter haftung (3080560) - roxithromycin - filmtablette - roxithromycin (23283) 300 milligramm
roxithromycin stada 150 mg filmtabletten
stadapharm, gesellschaft mit beschränkter haftung (3080560) - roxithromycin - filmtablette - roxithromycin (23283) 150 milligramm
roxithromycin accedo 300mg filmtabletten
awd.pharma gmbh & co. kg (8040743) - roxithromycin - filmtablette - roxithromycin (23283) 300 milligramm
arrow - roxithromycin 150
teva pharma (new zealand) limited - roxithromycin 150mg; - coated tablet - 150 mg - active: roxithromycin 150mg excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water - adults roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible micro-organisms: · upper respiratory tract infection - acute pharyngitis, tonsillitis and sinusitis · dental infections · lower respiratory tract infection - acute bronchitis; acute exacerbations of chronic bronchitis and community acquired pneumonia · skin and skin structure infections · non-gonococcal urethritis. children roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis, acute tonsillitis and impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.